interleukin genetics inc (ILIU:OTCQB)

Executive Profile*

Background*

Dr. Kenneth S. Kornman, Ken, D.D.S., PH.D. founded Interleukin Genetics, Inc. in 1986 and has been its Chief Executive Officer since August 23, 2012. Dr. Kornman also serves as the President, Chief Scientific Officer and Secretary of Interleukin Genetics, Inc. Dr. Kornman has also been a Consultant and scientific researcher for many major oral care and pharmaceutical companies. Dr. Kornman served as Chief Executive Officer of Interleukin Genetics Inc., from April 1, ... 2006 to August 17, 2006. Dr. Kornman served as a Chief Medical and Regulatory Officer of Interleukin Genetics, since December 16, 2003. Prior to that, he served as Department Chair and Professor at The University of Texas Health Science Center at San Antonio. Dr. Kornman has been a Director of Interleukin Genetics, Inc. since August 23, 2012 and previously served as its Director from August 17, 2006 to April 29, 2010. He serves as a Member of the Scientific Advisory Board of Nutrilite Health Institute. Dr. Kornman currently holds academic appointments at The University of Texas Health Science Center and Harvard University. Dr. Kornman holds six patents in the pharmaceutical area, has published three books and more than 100 articles and abstracts and has lectured and consulted worldwide on the transfer of technology to clinical practice. Dr. Kornman holds a BA in Economics from Duke University, Durham, North Carolina, USA and a D.D.S. from Emory University, Atlanta, Georgia, USA. Dr. Kornman also holds an M.S. in Periodontics from The University of Michigan, Ann Arbor, Michigan USA and a Ph.D. in Microbiology-Immunology from The University of Michigan, Ann Arbor, Michigan, USA.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
ILIU:US	$0.40 USD	0.00

COMPETITOR COMPENSATION